Envista Holdings Corp. (NVST) PT Raised to $19 at Mizuho

Mizuho analyst Steven Valiquette raised the price target on Envista Holdings Corp. (NYSE: NVST) to $19.00 (from $18.00) while maintaining a Underperform rating.

The analyst commented: "Among diversified dental manufacturers, NVST continued its trend of modest market share gains in 3Q25 from what we believe is a better-positioned product portfolio vs. broad dental peers, which drove ~5% adjusted "core growth" for NVST in 3Q25 (or ~9% core growth including Spark deferral). Total reported revenues were $670 mln (+11.5% y-o-y). Within this, Spark clear aligners witnessed double-digit reported sales growth (still benefited y-o-y vs. 2024 deferral adjustment), while dental implants witnessed positive growth for the fourth consecutive quarter, and dental consumables also witnessed double-digit growth. Overall, management raised 2025 EPS guidance modestly from $1.05-$1.15 to $1.10-$1.15, and increased core sales growth to ~4% from 3-4%, while maintaining ~14% EBITDA margin guide. We raise our 2025 EPS estimate from $1.07 to $1.15 and 2026 from $1.20 to $1.26 to reflect the market share gains cited above, which increases our PT to $19 from $18 on same 15x P/E."

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• BMO Capital Starts Energy Fuels (UUUU) at Outperform
• BMO Capital Resumes Snowline Gold Corp (SGD:CN) (SNWGF) at Outperform